Hyperuricemia and global Cardiovascular Risk: State of the art and preventive prospects

Angelo Michele Carella*, Teresa Marinelli, Armando Melfi tano, Michele Di Pumpo, Giovanni Modola and Angelo Benvenuto

Over the last years, scientific research has focused its interest on a potential role of hyperuricemia as cardiovascular risk factor; main interest has been directed to persistent raised plasma levels of uric acid. Although some studies have not shown a close correlation between hyperuricemia and cardiovascular risk, most scientific evidence agrees that hyperuricemia plays a key role in determining cardiovascular events and in development of other risk factors often associated with only moderately increased serum uric acid levels. Pathophysiological mechanism underlying this association mainly include a hyperuricemia induced endothelial dysfunction, inflammatory and oxidative stress induced by high serum uric acid levels. Early diagnosis, follow-up and prevention programs and effective treatment of hyperuricemia are recommended in particular in patients with other concomitant cardiovascular risk factors. Urate-lowering therapy should be aimed at reaching at least a serum uric acid level below 6 mg/dL (360 μmol/L) though in high risk patients the lowest possible value of uric acid is better.

Keywords: Hyperuricemia; Cardiovascular risk; Prevention

Published on: Jul 4, 2017 Pages: 22-27

Full Text PDF Full Text HTML DOI: 10.17352/apm.000008
CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat